BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Cisplatin
,
rs4950928
,
PRKCA
,
cell-cell adhesion
,
Obesity
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ly 22
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Palatal mesenchyme cells treated with PDGFA or FGF1 in combination with LY294002 or PD0325901
Diffuse large B-cell lymphoma U-2932 and OCI-LY-7 cells treated with trabectedin
Explore Curated Studies Results
Literature
Most Relevant Literature
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes.
L-selectin regulates human neutrophil transendothelial migration.
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psori…
Exogenous Melatonin Up-Regulates Expression of CD62L by Lymphocytes in Aged Mice under Inflammatory …
Molecular Dynamics of the Association of L-Selectin and FERM Regulated by PIP2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
Biobehavioral Efficacy of the Semi-Elevated Side-Lying Position
Mode of Delivery in Women With Low-lying Placenta
Hydrotherapy CP and Lying Down to Sitting Position
A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ